Drug Discovery market research reports by DelveInsight

• Angiotensin Modulators - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Angiotensin Modulators - Pipeline Insight, 2024 “Angiotensin Modulators - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin Modulators development. The report provides detaile ... Read More

• Antiapoptotic Protein Targeted Degradation - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Antiapoptotic Protein Targeted Degradation - Pipeline Insight, 2024 Antiapoptotic Protein Targeted Degradation Overview ""Antiapoptotic Protein Targeted Degradation Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth pros ... Read More

• Aortic Stenosis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Aortic Stenosis - Pipeline Insight, 2024 Aortic Stenosis Overview ""Aortic Stenosis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Aortic Stenosis market. A detailed picture of the Aortic Stenosi ... Read More

• Alpha Receptor Agonist - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Alpha Receptor Agonist - Pipeline Insight, 2024 “Alpha Receptor Agonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha Receptor Agonist development. The report provides detaile ... Read More

• Alpha-1 Antagonist - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Alpha-1 Antagonist - Pipeline Insight, 2024 “Alpha-1 Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-1 Antagonist development. The report provides detailed coverage o ... Read More

• Alpha-1A Antagonist - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Alpha-1A Antagonist - Pipeline Insight, 2024 “Alpha-1A Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-1A Antagonist development. The report provides detailed coverag ... Read More

• AMPA Receptor Antagonist - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  AMPA Receptor Antagonist - Pipeline Insight, 2024 “AMPA Receptor Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across AMPA Receptor Antagonist development. The report provides d ... Read More

• Amyloid Protein Blockers - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Amyloid Protein Blockers - Pipeline Insight, 2024 “Amyloid Protein Blockers - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Amyloid Protein Blockers development. The report provides d ... Read More

• Androgen Agonist - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Androgen Agonist - Pipeline Insight, 2024 “Androgen Agonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Androgen Agonist development. The report provides detailed coverage of the ... Read More

• Anesthetic Effect - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Anesthetic Effect - Pipeline Insight, 2024 Anesthetic Effect Overview ""Anesthetic Effect Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Anesthetic Effect market. A detailed picture of the Anesth ... Read More

• Angiotensin Receptor Agonist - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Angiotensin Receptor Agonist - Pipeline Insight, 2024 “Angiotensin Receptor Agonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin Receptor Agonist development. The repor ... Read More

• Antimicrobial Resistance (AMR) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Antimicrobial Resistance (AMR) - Pipeline Insight, 2024 Antimicrobial Resistance (AMR) Overview ""Antimicrobial Resistance (AMR) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Antimicrobial Resis ... Read More

• Anus Neoplasms - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Anus Neoplasms - Pipeline Insight, 2024 Anus Neoplasms Overview ""Anus Neoplasms Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Anus Neoplasms market. A detailed picture of the Anus Neoplasms pip ... Read More

• Astigmatism - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Astigmatism - Pipeline Insight, 2024 Astigmatism Overview ""Astigmatism Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Astigmatism market. A detailed picture of the Astigmatism pipeline landscape ... Read More

• idiopathic Multicentric Castleman's disease (iMCD) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  idiopathic Multicentric Castleman's disease (iMCD) - Pipeline Insight, 2024 idiopathic Multicentric Castleman's disease (iMCD) Overview ""idiopathic Multicentric Castleman's disease (iMCD) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development ... Read More

• Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist - Pipeline Insight, 2024 “Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under ... Read More

• Nocturnal Enuresis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Nocturnal Enuresis - Pipeline Insight, 2024 Nocturnal Enuresis Overview ""Nocturnal Enuresis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Nocturnal Enuresis market. A detailed picture of the No ... Read More

• Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024 DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Inhibitors pipeline landscape. I ... Read More

• Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024 DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024,” report provides comprehensive insights about 3+ companies and 3+ pipeline ... Read More

• Potassium channel antagonists - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Potassium channel antagonists - Pipeline Insight, 2024 DelveInsight’s, “Potassium channel antagonists - Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Potassium channel antagonists pipeline landscape. It covers the pipeline drug profiles, ... Read More

• Glioblastoma- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 5,000

  Glioblastoma- Pipeline Insight, 2024 DelveInsight’s, “Glioblastoma- Pipeline Insight, 2024” report provides comprehensive insights about 195+ companies and 210+ pipeline drugs in Glioblastoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More

• Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2024 DelveInsight’s, “Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2024” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Glucagon-Like Peptide 1 Receptor Agonists pipeline landscape. I ... Read More

• G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2024 “G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across G-Protein Coupled Recepto ... Read More

• Glabellar Lines - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Glabellar Lines - Pipeline Insight, 2024 DelveInsight’s, “Glabellar Lines - Pipeline Insight, 2024,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Glabellar Lines pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage p ... Read More

• TYK2 kinase inhibitors - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  TYK2 kinase inhibitors - Pipeline Insight, 2024 DelveInsight’s, “TYK2 Kinase Inhibitors - Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in TYK2 Kinase Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical a ... Read More

< prev 40 41 42 43 44 45 46 47 48 49 next >